Our Story

At a national conference on mucopolysaccharidosis in 2019, we asked the speaker about how to improve diagnosis through educating physicians. A few minutes later, a handwritten note was left on the table where we sat. The note was from “Aaron’s mom” who thanked us for raising the question that has been on her mind for a long time.

At P2P Syncro, our mission is to help clinicians keep abreast with medical breakthroughs at a time when more and more uncharted disease areas are being tackled with novel therapies. We want to tell Aaron’s mom that the lives of patients like her son can be improved. 


Our Solution

Create Content

We listen to patients’ stories. We interview parents of children affected by the disease. We apply the concept of machine learning in content development.

Conduct Campaigns

Our campaign message is tailored to the learning need of each provider specialty involved in the patient journey. It is created to enable actions.

Deliver Programs

We build modern-day content delivery platforms to drill minds and hammer concept. We engage our audience with AI based activities.

Evaluate Impact

We are the first to use objective real-world evidence to demonstrate the impact of educational efforts in rare diseases. Making real change is our goal.


Our Work

Early Diagnosis
"My Son Had the Common Things"  - The Common and Uncommon Things in Mucopolysaccharidosis
Neuroendocrine tumor
Diagnosis and Treatment
The Wolf In Sheep's Clothing  -  Diagnosis and Management of Neuroendocrine Tumors
Emerging Therapy
What Is Coming from the Pipeline and What Is Updated in the Guideline - Primary Biliary Cholangitis